Cytocom is a Colorado-based biopharmaceutical company that develops and commercializes immunotherapies for the treatment of autoimmune and cancer diseases.
Business Model:
Revenue: $262.9k
Employees: 2-10
Address: 2537 Research Blvd
City: Fort Collins
State: CO
Zip: 80526
Country: US
Cytocom is a Colorado-based biopharmaceutical company that develops and commercializes immunotherapies for the treatment of autoimmune and cancer diseases.
Contact Phone:
+18886294155
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
7/28/2021
Ticker Symbol:
CBLI
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2021 | Post-IPO Equity | 1 | $75M |
The Global Emerging Markets Group The Global Emerging Markets Group |
7/2021 | Post-IPO Equity | $90M |
GEM Global Yield LLC Avenue Capital Adit Ventures |
7/2021 | Post-IPO Debt | $0 |
Adit Ventures Avenue Capital Group Adit Ventures Avenue Capital Group |
6/2018 | Equity | - | 7/2020 | Venture Round | $2.3M | 6/2018 | Equity | - |
Immune Therapeutics, Inc., Immune Therapeutics, Inc., |
7/2021 | Post-IPO Debt | 2 | $17M |
Adit Ventures Avenue Capital Group Adit Ventures Avenue Capital Group |
---|
Announced Date | Name | Price |
---|---|---|
10/2020 | Cleveland BioLabs | |
7/2020 | ImQuest Life Sciences |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|